Evolving Landscape of Regulatory Medicine
Last updated on Dec 14, 2020
We are evaluating the evolving landscape of regulatory medicine in Cutaneous Oncology and Dermatology
Medical Oncologist and Dermatologist
My research interests include clinical and translational research in advanced skin cancers.
We evaluate the fragility of pivotal trials used to support FDA approval in Plaque Psoriasis.
Analysis of the changing regulatory environment in skin cancer
Sep 9, 2020 6:30 PM — 7:30 PM UMass Memorial Department of Dermatology
Dec 13, 2019 1:00 PM — 3:00 PM Columbia University Medical Center
Apr 2, 2019 9:00 AM — 10:00 AM Massachusetts General Hospital
Reducing M&M in M&M - Strategies to improve Morbidity and Mortality in Melanoma and Merkel cell carcinoma
Dec 19, 2018 8:30 AM — 9:00 AM Beth Israel Deaconess Medical Center
Overview of regulatory medicine in skin cancer
Nov 9, 2018 1:00 PM — 2:00 PM Columbia University Medical Center